眼科用薬物送達市場 - 2031年の成長予測、統計および事実

  • Report Code : TIPRE00004206
  • Category : Pharmaceuticals
  • Status : Published
  • No. of Pages : 171
Buy Now

眼科用ドラッグデリバリー市場は、2021 年に 164 億 432 万米ドルと評価され、2028 年までに 270 億 1,620 万米ドルに達すると予測されています。 2021 年から 2028 年にかけて 7.4 % の CAGR で成長すると予想されています。 

眼科ドラッグ デリバリー システム (ODDS) は、剤形、ビヒクル、または視覚に関わる、または視覚に影響を与える病気や障害に対して、薬物/医薬品を眼に点滴、投与、または送達することを目的としたシステム。それは、眼表面用の単純な滅菌点眼薬から眼内組織用の複雑なインプラントまで多岐にわたります。眼科用薬剤製剤は、前眼部疾患を治療するための溶液、懸濁液、乳濁液などの主に液体の形態です。これらの製剤は、in-situ ゲル、マイクロエマルション、ナノ粒子、リポソーム、イオン導入、ナノサスペンション、眼球インサートなどの高度なドラッグ デリバリー システムの形で入手できます。     

戦略的洞察                        

眼科ドラッグデリバリー市場は、技術、製剤の種類、疾患の種類、エンドユーザー、および地理に基づいて分割されています。地理的には、市場は主に北米、ヨーロッパ、アジア太平洋、中東、およびアジア太平洋地域に分割されています。アフリカ、そして南と南。中米。このレポートは、眼科ドラッグデリバリー市場の洞察と詳細な分析を提供し、世界をリードする市場プレーヤーの競争状況分析とともに、市場動向、技術進歩、市場力学などのパラメーターを強調しています。  

眼科用ドラッグデリバリー市場の有利な地域

市場洞察
眼科薬物送達市場の成長を促進する眼疾患の有病率の増加

世界中の失明または視力低下の主な原因は、白内障、緑内障、加齢です黄斑変性症、糖尿病性網膜症、未解決の屈折異常など。世界人口の大多数は、生涯のうちに何らかの眼疾患を患っている、または患っていました。世界保健機関 (WHO) の報告書「失明と視覚障害」によると、 2021 年 2 月に発表された論文によると、世界中で約 22 億人が近方または遠方の視覚障害を抱えています。また、視力喪失または弱視の主な原因は白内障(9,400万人)と未矯正の屈折異常(8,840万人)であると推定されています。さらに、その他の一般的な視力喪失の原因は、緑内障 (770 万人)、角膜混濁 (420 万人)、糖尿病性網膜症 (390 万人)、トラコーマ (200 万人) です。

国立眼科研究所 (NEI) によると、米国では白内障患者の数が 2010 年の 2,440 万人から 2050 年には約 5,000 万人に倍増すると予想されています。 2019 年の数字では、米国では 300 万人以上が緑内障を抱えています。 さらに、2017 年のカナダ障害者調査によると、150 万人のカナダ人が失明し、約 559 万人がさらに失明につながる可能性のある眼疾患を患っています。

さらに、 2017年の王立国立盲人研究所によると、英国では約35万人が盲目および弱視者として登録されている。約173,735人が重度視覚障害者として登録されている。 176,125 人が視覚障害者として登録されています。  

テクノロジーベースの洞察                ;                

テクノロジーに基づく眼科ドラッグデリバリー市場は、移植可能な眼科薬物送達システム、粒子薬物送達システム、ナノ粒子薬物送達システムなどに分類されます。植込み型眼科ドラッグデリバリーシステムセグメントは、2021 年に最大の市場シェアを占めると予想されており、同セグメントは予測期間中に最高の CAGR を記録すると予想されます。

眼科用ドラッグデリバリー市場、テクノロジー別 – 2021 年と 2028 年

製剤タイプベースの分析情報       ;                 

製剤の種類に基づいて、眼科薬送達市場は、リポソームとナノ粒子、溶液、エマルション、懸濁液、および軟膏に分類されます。ソリューションセグメントは 2021 年に市場で最大のシェアを保持し、2021 年から 2028 年にかけて市場で最高の CAGR を記録すると推定されています。ソリューション部門の成長は、点眼薬や注射剤などの溶液形態での眼用ドラッグデリバリーシステムの採用の増加によるものです。

疾患の種類に基づく洞察

疾患の種類に基づく洞察

p>

眼科ドラッグデリバリー市場は、疾患の種類に基づいて、緑内障、糖尿病性網膜症、ドライアイ症候群、黄斑変性症、白内障、糖尿病性黄斑浮腫などに分類されます。白内障セグメントは、2021 年に最大の市場シェアを占めると予想されます。このセグメントの市場は、2021 年から 2028 年にかけて最も高い CAGR で成長すると推定されています。

エンドユーザー–ベースの洞察

眼科ドラッグデリバリー市場は、エンドユーザーに基づいて、病院、眼科クリニック、外来手術センターに分類されます。 2021 年には病院セグメントが市場で最大のシェアを握ると予想され、一方で眼科クリニックセグメントは予測期間中に市場で最も高い CAGR を記録すると推定されています。

< p>新型コロナウイルス感染症(COVID-19)のパンデミックは、世界中で最も重大な課題となっています。このパンデミックにより世界中の医療システムが圧迫されているため、入院を最小限に抑えるためには限られたリソースを優先することが不可欠でした。しかし、点眼薬、軟膏、懸濁液などの眼科治療薬の需要が増加したにもかかわらず、新規消費者が市場に参入したため、これらの製品が不足していました。メーカーはまた、供給制限による価格上昇や原材料不足の可能性にも直面している。しかし、制限が解除されビジネスが再開されるにつれ、需要と供給の変数は正常に戻りつつあります。これにより、眼科用薬物送達治療薬にいくつかの成長の見通しがもたらされます。   

買収、提携、提携、製品発売、拡張は、一般的に採用される戦略です。企業は世界中に拠点を拡大し、増大する需要に対応します。眼科用ドラッグデリバリー市場のプレーヤーは、世界中で変化する顧客の需要に応えるために主に製品イノベーション戦略を採用しており、これは自社のブランド名を世界的に維持するのにも役立っています。

< p>会社概要

  • アッヴィ株式会社                  ;                        
  • Bausch Health Companies Inc.                
  • 台湾リポソーム株式会社             
  • Ocular Therapeutix, Inc.                         
  • GRAYBUG VISION, INC.                          
  • Alimera Sciences, Inc.                          
  • Envisia Therapeutics                              
  • ノバルティス AG                                         
  • EYEGATE PHARMACEUTICALS, INC           
  • Clearside Biomedical, Inc.
Report Coverage
Report Coverage

Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

Segment Covered
Segment Covered

This text is related
to segments covered.

Regional Scope
Regional Scope

North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

Country Scope
Country Scope

This text is related
to country scope.

Frequently Asked Questions


What is ocular drug delivery?

Ocular drug delivery system (ODDS) is a dosage form, vehicle, or system intended for instilling, administering, or delivering drug/medicine to eye against any ailment or disorder involving or affecting vision. It ranges from simple sterile eye drop for the ocular surface to complex implants for intraocular tissue. Ocular drugs formulations are primarily available in liquid form such as solutions, suspensions, and emulsions for treating anterior eye segment diseases. These formulations can be available in the form of advanced drug delivery systems like in-situ gel, microemulsion, nanoparticle, liposome, iontophoresis, nanosuspension, and ocular inserts.

What are the driving factors for the Ocular drug delivery market across the globe?

The factors that are driving growth of the market are growing prevalence of eye disorders and rising research on ocular drug delivery.

What are the challenges hindering the adoption of Ocular drug delivery?

The factors that are restraining the adoption of ocular drug delivery are several disadvantages associated with ocular drug delivery.

Who are the major players in the Ocular drug delivery market?

The Ocular drug delivery market majorly consists of the players such as players AbbVie Inc., Bausch Health Companies Inc., Taiwan Liposome Company, Ltd., Ocular Therapeutix, Inc., Graybug Vision, Inc., Alimera Sciences, Inc., Envisia Therapeutics, Novartis AG, EyeGate Pharmaceuticals, Inc, Clearside Biomedical, Inc. and among others.

The List of Companies - Ocular Drug Delivery Market

  1. AbbVie Inc.          
  2. Bausch Health Companies Inc.      
  3. Taiwan Liposome Company, Ltd.              
  4. Ocular Therapeutix, Inc.    
  5. GRAYBUG VISION, INC.               
  6. Alimera Sciences, Inc.      
  7. Envisia Therapeutics         
  8. Novartis AG         
  9. EYEGATE PHARMACEUTICALS, INC        
  10. Clearside Biomedical, Inc.

The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

  1. Data Collection and Secondary Research:

As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.

  1. Primary Research:

The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

A typical research interview fulfils the following functions:

  • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
  • Validates and strengthens in-house secondary research findings
  • Develops the analysis team’s expertise and market understanding

Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

  • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
  • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

Below is the breakup of our primary respondents by company, designation, and region:

Research Methodology

Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

  1. Data Analysis:

Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

  • Macro-Economic Factor Analysis:

We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

  • Country Level Data:

Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

  • Company Profile:

The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

  • Developing Base Number:

Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

  1. Data Triangulation and Final Review:

The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.

Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Related Reports